Comparison the effects of Dexmedetomidine and Labetalol on blood pressure in maxillofacial fractures surgery
Phase 3
- Conditions
- Fracture of mandible.Fracture of mandibleS02.6
- Registration Number
- IRCT20170408033291N3
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Ages 18 to 60 years
Class 1 & 2 of American Anesthesiologists (ASA) Association Classification
Fracture of mandible or maxilla
Exclusion Criteria
Class 3 or more of American Anesthesiologists (ASA) Association Classification
Heart Block
Heart Failure
Unstable Hemodynamic
Depression
Renal Failure
Raynaud's phenomenon
Sensitivity to lidocaine or beta-blockers
Deformity of Trachea
Lack of consent to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Systolic blood pressure. Timepoint: Before surgery, after intubation, after induction of hypotension, after bolus dose, 3, 5, 10, 15, 30, 60 min after bolus dose, end of operation and recovery. Method of measurement: Using a blood pressure monitor device.;Diastolic blood pressure. Timepoint: Before surgery, after intubation, after induction of hypotension, after bolus dose, 3, 5, 10, 15, 30, 60 min after bolus dose, end of operation and recovery. Method of measurement: Using a blood pressure monitor device.;Mean arterial blood pressure. Timepoint: Before surgery, after intubation, after induction of hypotension, after bolus dose, 3, 5, 10, 15, 30, 60 min after bolus dose, end of operation and recovery. Method of measurement: Using a blood pressure monitor device.
- Secondary Outcome Measures
Name Time Method Heart Rate. Timepoint: Before surgery, after intubation, after induction of hypotension, after bolus dose, 3, 5, 10, 15, 30, 60 min after bolus dose, end of operation and recovery. Method of measurement: Using cardiac monitoring device.